These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1924062)

  • 1. Delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Cummins D; Webb G; Shah N; Davies SC
    Postgrad Med J; 1991 Jul; 67(789):689-91. PubMed ID: 1924062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Gardner K; Hoppe C; Mijovic A; Thein SL
    Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hemolytic transfusion reaction due to anti-D in a D+ patient with sickle cell disease.
    Ipe TS; Wilkes JJ; Hartung HD; Westhoff CM; Chou ST; Friedman DF
    J Pediatr Hematol Oncol; 2015 Mar; 37(2):e135-7. PubMed ID: 25171447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F
    Transfus Clin Biol; 2012 Jun; 19(3):132-8. PubMed ID: 22818360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion Therapy in Children With Sickle Cell Disease.
    Inati A; Mansour AG; Sabbouh T; Amhez G; Hachem A; Abbas HA
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):126-132. PubMed ID: 27509379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic transfusion reaction after preoperative prophylactic blood transfusion for sickle cell disease in pregnancy.
    Proudfit CL; Atta E; Doyle NM
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):471-4. PubMed ID: 17666632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transfusion and sickle cell disease: axes of transfusion safety optimization].
    Noizat-Pirenne F
    Transfus Clin Biol; 2014 May; 21(2):77-84. PubMed ID: 24811565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients].
    Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA
    Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematologic emergencies. Management of transfusion reactions and crises in sickle cell disease.
    Dabrow MB; Wilkins JC
    Postgrad Med; 1993 Apr; 93(5):183-90. PubMed ID: 8460076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Delayed haemolytic transfusion reaction: About 3 patients with sickle cell disease].
    Bertrand E; Dumesnil C; Lahary A; Al Bagami M; Schneider P; Lévesque H; Vannier JP
    Rev Med Interne; 2015 Nov; 36(11):769-72. PubMed ID: 25529378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Vidler JB; Gardner K; Amenyah K; Mijovic A; Thein SL
    Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of delayed hemolytic transfusion reaction.
    Pirenne F
    Transfus Clin Biol; 2019 May; 26(2):99-101. PubMed ID: 30926306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell alloimmunization: lessons from sickle cell disease.
    Treml A; King KE
    Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction.
    Cullis JO; Win N; Dudley JM; Kaye T
    Vox Sang; 1995; 69(4):355-7. PubMed ID: 8751307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transfusion crises in sickle cell anemia.
    Milner PF; Squires JE
    Prog Clin Biol Res; 1987; 240():351-9. PubMed ID: 3615499
    [No Abstract]   [Full Text] [Related]  

  • 19. Delayed hemolytic transfusion reactions in sickle cell anemia.
    Rao KR; Patel AR
    South Med J; 1989 Aug; 82(8):1034-6. PubMed ID: 2762885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells.
    Vichinsky EP
    Immunohematology; 2012; 28(1):20-3. PubMed ID: 22646146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.